A Bayesian population PBPK model for multiroute chloroform exposure

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Exposure Science and Environmental Epidemiology

• Publication date

  2010-06-01

• Fields of study

  Medicine, Chemistry, Environmental Science

• Identifiers
  DOI 10.1038/jes.2009.29PMID 19471319PMCID PMC3063650
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Quantitative interpretation of human biomonitoring data.

  2008influential reference
• Optimal design

  2007cited by this paper
• Bayesian Estimation of Pharmacokinetic and Pharmacodynamic Parameters in a Mode‐of‐Action‐Based Cancer Risk Assessment for Chloroform

  2007cited by this paper
• Bayesian population analysis of a harmonized physiologically based pharmacokinetic model of trichloroethylene and its metabolites.

  2006cited by this paper
• Revised assessment of cancer risk to dichloromethane: part I Bayesian PBPK and dose-response modeling in mice.

  2006influential reference
• Development of Physiologically Based Toxicokinetic Models for Improving the Human Indoor Exposure Assessment to Water Contaminants: Trichloroethylene and Trihalomethanes

  2006cited by this paper
• Use of a Physiologically Based Pharmacokinetic Model to Identify Exposures Consistent With Human Biomonitoring Data for Chloroform

  2006influential reference
• Dermal uptake of chloroform and haloketones during bathing

  2005cited by this paper
• Evaluation of Physiologically Based Pharmacokinetic Models in Risk Assessment: An Example with Perchloroethylene

  2005cited by this paper
• A source-to-dose assessment of population exposures to fine PM and ozone in Philadelphia, PA, during a summer 1999 episode

  2005cited by this paper
• Human respiratory uptake of chloroform and haloketones during showering

  2005influential reference
• Senescence alters blood flow responses to acute heat stress.

  2004cited by this paper
• Reconstructing population exposures from dose biomarkers: inhalation of trichloroethylene (TCE) as a case study

  2004cited by this paper
• Toxicokinetic modeling and its applications in chemical risk assessment.

  2003cited by this paper
• Predicting fetal perchlorate dose and inhibition of iodide kinetics during gestation: a physiologically-based pharmacokinetic analysis of perchlorate and iodide kinetics in the rat.

  2003cited by this paper
• Modeling Interindividual Variation in Physiological Factors Used in PBPK Models of Humans

  2003cited by this paper
• Skin blood flow in adult human thermoregulation: how it works, when it does not, and why.

  2003cited by this paper
• The cytochrome P-450 isoenzyme CYP2E1 in the biological processing of industrial chemicals: consequences for occupational and environmental medicine

  2003cited by this paper
• Population toxicokinetic analysis of 2,3,7,8‐tetrachlorodibenzo‐p‐dioxin using Bayesian techniques

  2002cited by this paper
• Improving Risk Assessment: Research Opportunities in Dose Response Modeling to Improve Risk Assessment

  2002cited by this paper
• Improving Risk Assessment: Priorities for Epidemiologic Research

  2002cited by this paper
• Basic anatomical and physiological data for use in radiological protection: reference values

  2002cited by this paper
• Percutaneous absorption of trihalomethanes, haloacetic acids, and haloketones.

  2002cited by this paper
• Modelling and simulation of variability and uncertainty in toxicokinetics and pharmacokinetics.

  2001cited by this paper
• Physiologically based pharmacokinetic modeling of inhalation exposure of humans to dichloromethane during moderate to heavy exercise.

  2001influential reference
• Bayesian estimation of variability in adipose tissue blood flow in man by physiologically based pharmacokinetic modeling of inhalation exposure to toluene.

  2001cited by this paper
• Statistical issues in toxicokinetic modeling: a bayesian perspective.

  2000cited by this paper
• Statistical analysis of Clewell et al. PBPK model of trichloroethylene kinetics.

  2000cited by this paper
• Statistical analysis of Fisher et al. PBPK model of trichloroethylene kinetics.

  2000influential reference
• Development of a physiologically based pharmacokinetic model of trichloroethylene and its metabolites for use in risk assessment.

  2000cited by this paper
• Physiologically based pharmacokinetic modeling of the temperature-dependent dermal absorption of chloroform by humans following bath water exposures.

  2000influential reference
• Evaluation of the health risk associated with exposure to chloroform in indoor swimming pools.

  2000influential reference
• Penetration of chloroform, trichloroethylene, and tetrachloroethylene through human skin.

  1999cited by this paper
• Analysis of PBPK Models for Risk Characterization

  1999cited by this paper
• Cardiovascular Responses to a Hot Tub Bath

  1999cited by this paper
• Optimal design for a study of butadiene toxicokinetics in humans.

  1999cited by this paper
• Comparison of responses of men to immersion in circulating water at 40.0 and 41.5 degrees C.

  1998cited by this paper
• General methods for monitoring convergence of iterative simulations

  1998cited by this paper
• Cardiovascular Responses in a Whirlpool Bath at 40°C Versus User-Controlled Water Temperatures

  1998cited by this paper
• Cardiovascular responses in a whirlpool bath at 40 degrees C versus user-controlled water temperatures.

  1998cited by this paper
• Effect of water temperature on dermal exposure to chloroform.

  1998influential reference
• Human Exposure and Body Burden for Chloroform and Other Trihalomethanes

  1997cited by this paper
• Toxicological profile for Chloroform.

  1997cited by this paper
• Modeling the effects of water usage and co-behavior on inhalation exposures to contaminants volatilized from household water.

  1996cited by this paper
• Population toxicokinetics of benzene.

  1996cited by this paper
• Physiological Pharmacokinetic Analysis Using Population Modeling and Informative Prior Distributions

  1996cited by this paper
• Population toxicokinetics of tetrachloroethylene

  1996cited by this paper
• In vivo and in vitro characterization of CYP2E1 activity in Japanese and Caucasians.

  1996cited by this paper
• Effects of bathing in hot water on portal hemodynamics in healthy subjects and in patients with compensated liver cirrhosis.

  1995cited by this paper
• A distributed parameter physiologically-based pharmacokinetic model for dermal and inhalation exposure to volatile organic compounds.

  1995influential reference
• Risk assessment: toxicity from chemical exposure resulting from enhanced expression of CYP2E1.

  1995influential reference
• Sensitivity of physiologically based pharmacokinetic models to variation in model parameters: methylene chloride.

  1994cited by this paper
• Human cardiovascular responses to a 60-min bath at 40 degrees C.

  1994cited by this paper
• Metabolically consistent breathing rates for use in dose assessments.

  1993cited by this paper
• Interindividual differences in the in vitro conjugation of methylene chloride with glutathione by cytosolic glutathione S-transferase in 22 human liver samples.

  1993cited by this paper
• Handbook of Clinical Anesthesia

  1991cited by this paper
• Assessing, accommodating, and interpreting the influences of heterogeneity.

  1991cited by this paper
• Routes of chloroform exposure and body burden from showering with chlorinated tap water.

  1990cited by this paper
• Changes in human skin blood flow by hyperthermia.

  1990cited by this paper
• Development of a physiologically based pharmacokinetic model for chloroform.

  1990influential reference
• Exposure factors handbook

  1989cited by this paper
• Spreadsheet programming--a new approach in physiologically based modeling of solvent toxicokinetics.

  1988cited by this paper
• HUMTRN: documentation and verification for an ICRP-based age- and sex-specific human simulation model for radionuclide dose assessment

  1984cited by this paper
• Glomerular filtration and renal plasma flow during hyperthermia.

  1960cited by this paper

• Informatics for toxicokinetics

  2025cites this paper
• From blood to body tissues: a dynamic framework for estimating volatile organic compound exposure using Kalman filtering and physiological models

  2025cites this paper
• Human health risk assessment of occupational exposure to NORMs using deterministic and Monte Carlo-based methods: a case study of artisanal gold mining areas

  2025cites this paper
• Determining priority control factors for heavy metal management in urban road dust based on source-oriented probabilistic ecological-health risk assessment: A study in Xi'an during peak pollution season.

  2024cites this paper
• Bayesian PBPK modeling using R/Stan/Torsten and Julia/SciML/Turing.Jl

  2023cites this paper
• Exploring Route-Specific Pharmacokinetics of PFAS in Mice by Coupling in Vivo Tests and Physiologically Based Toxicokinetic Models

  2023cites this paper
• Reconstruction of exposure to methylene diphenyl-4,4′-diisocyanate (MDI) aerosol using computational fluid dynamics, physiologically based toxicokinetics and statistical modeling

  2023cites this paper
• Population Pharmacokinetics/PD Modelling: a Systematic Review

  2022cites this paper
• Human health risk assessment for contaminated sites: A retrospective review.

  2022cites this paper
• Human skin responses to environmental pollutants: A review of current scientific models.

  2022cites this paper
• Key Factors for Improving the Carcinogenic Risk Assessment of PAH Inhalation Exposure by Monte Carlo Simulation

  2021cites this paper
• Determination of priority control factors for the management of soil trace metal(loid)s based on source-oriented health risk assessment.

  2021cites this paper
• Bayesian Refinement of the Permeability-Limited Physiologically Based Pharmacokinetic Model for Perfluorooctanoic Acid in Male Rats.

  2021cites this paper
• Simultaneous Ivabradine Parent-Metabolite PBPK/PD Modelling Using a Bayesian Estimation Method

  2020cites this paper
• High inter-species differences of 12378-polychlorinated dibenzo-p-dioxin between humans and mice.

  2020cites this paper
• Estimating seasonal variations of realistic exposure doses and risks to organs due to ambient particulate matter -bound metals of Delhi.

  2020cites this paper
• Bayesian population physiologically-based pharmacokinetic model for robustness evaluation of withdrawal time in tilapia aquaculture administrated to florfenicol.

  2020cites this paper
• Development of a generic lifelong physiologically based biokinetic model for exposome studies.

  2020cites this paper
• Bayesian evaluation of a physiologically based pharmacokinetic (PBPK) model for perfluorooctane sulfonate (PFOS) to characterize the interspecies uncertainty between mice, rats, monkeys, and humans: Development and performance verification.

  2019cites this paper
• PBTK model for assessment of operator exposure to haloxyfop using human biomonitoring and toxicokinetic data

  2019cites this paper
• Physiology-based toxicokinetic modelling in the frame of the European Human Biomonitoring Initiative.

  2019cites this paper
• Critical assessment and integration of separate lines of evidence for risk assessment of chemical mixtures

  2019cites this paper
• Studies on the Response of Different Silkworm (Bombyx mori L.) Breeds to Chloroform Exposure at Different Time Durations

  2019cites this paper
• Modeling Complex Exposures

  2018cites this paper
• Informatics and Data Analytics to Support Exposome-Based Discovery: Part 1 - Assessment of External and Internal Exposure

  2018cites this paper
• Probabilistic modeling of aggregate lead exposure in children of urban China using an adapted IEUBK model.

  2017cites this paper
• Evaluation and calibration of high-throughput predictions of chemical distribution to tissues

  2017cites this paper
• Pharmacokinetic Model and Bayesian Simulation to Improve 2 Arsenic Non-Cancer Dose-Response 3

  2016cites this paper
• Personal Exposure and Dose of Inhaled Ambient Particulate Matter Bound Metals in Five European Cities

  2016cites this paper
• Using publicly available data, a physiologically-based pharmacokinetic model and Bayesian simulation to improve arsenic non-cancer dose-response.

  2016cites this paper
• Incorporation of stochastic variability in mechanistic population pharmacokinetic models: handling the physiological constraints using normal transformations

  2015cites this paper
• Development and applications of physiologically-based pharmacokinetic models for population data analyses

  2015cites this paper
• Combining the ‘bottom up’ and ‘top down’ approaches in pharmacokinetic modelling: fitting PBPK models to observed clinical data

  2015cites this paper
• A Novel Method for Assessing Drug Degradation Product Safety Using Physiologically-Based Pharmacokinetic Models and Stochastic Risk Assessment.

  2015cites this paper
• Uncertainties in human health risk assessment of environmental contaminants: A review and perspective.

  2015cites this paper
• Influence of Sexual Dimorphism on Pulmonary Inflammatory Response in Adult Mice Exposed to Chloroform

  2015cites this paper
• An Analysis of Whole Body Tracer Kinetics in Dynamic PET Studies With Application to Image-Based Blood Input Function Extraction

  2014cites this paper
• Toxicokinetic Modeling of Ethyl Paraben Administered Orally in Rats

  2014cites this paper
• Using Bayesian-PBPK modeling for assessment of inter-individual variability and subgroup stratification

  2013influential citation
• ГиГиениЧеСКаЯ оЦенКа Прод УКТоВ ХЛорироВаниЯ ПиТЬеВоЙ ВодЫ С УЧеТ оМ МножеСТВенно СТи ПУТеЙ По СТУПЛениЯ В орГ аниЗМ

  2013cites this paper
• A multi-route model of nicotine-cotinine pharmacokinetics, pharmacodynamics and brain nicotinic acetylcholine receptor binding in humans.

  2013cites this paper
• A Case Study of Landfill Workers Exposure and Dose to Particulate Matter-Bound Metals

  2013cites this paper
• Development of lead source-specific exposure standards based on aggregate exposure assessment: Bayesian inversion from biomonitoring information to multipathway exposure.

  2012cites this paper
• Modeling of absorption.

  2012cites this paper
• Caractérisation de la composante toxicocinétique du facteur d’ajustement pour la variabilité interindividuelle utilisé en analyse du risque toxicologique

  2011cites this paper
• exposure-Population Pharmacokinetics/PD Modelling: a Systematic Review

  year unknowncites this paper